Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors-Reference-Cited by-同舟云学术

Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors

Published:2003-12 Issue:6 Volume:42 Page:1154-1163
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Pozzi Claudio,D'Amico Marco,Fogazzi Giovanni B,Curioni Simona,Ferrario Franco,Pasquali Sonia,Quattrocchio Giacomo,Rollino Cristiana,Segagni Siro,Locatelli Francesco

Publisher

Elsevier BV

Subject

Nephrology

Reference25 articles.

1. Manifestations of systemic light chain deposition;Randall;Am J Med,1976

2. The patient with insidious chronic renal failure and the patient with the nephrotic syndrome—Two manifestations of a protean and not so rare disease;Pozzi;Nephrol Dial Transplant,1996

3. Renal disease and patient survival in light chain deposition disease;Pozzi;Clin Nephrol,1995

4. Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease;Heilman;Am J Kidney Dis,1992

5. Renal monoclonal immunoglobulin deposition disease;Lin;J Am Soc Nephrol,2001

Cited by 276 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translocation (11;14) is a common cytogenetic abnormality in clonal plasma cells in monoclonal immunoglobulin deposition disease;British Journal of Haematology;2024-09-06

2. Light chain deposition disease: pathogenesis, clinical characteristics and treatment strategies;Annals of Hematology;2024-08-28

3. Multimodal Imaging of Bilateral Retinal Pigment Epithelial Immunoglobulin Light Chain Deposition in Patients with Systemic Immunoglobulin Light Chain Deposition;Ophthalmology Retina;2024-07

4. Light chain deposition disease presenting with gastrointestinal disorder as primary manifestation: report of two cases and literature review;Journal of International Medical Research;2024-03

5. Poems Syndrome and Disease Produced by Other Monoclonal IGs;The EBMT Handbook;2024